The Preeclampsia Foundation. New guidelines in preeclampsia diagnosis and care Include revised definition of preeclampsia. Melbourne, FL USA;2013.

Eiland E, Nzerue C, Faulkner M. Preeclampsia. J Pregnancy 2012;2012. doi: 10.1155/2012/586578.

Ardian M, Dachlan E. The characteristic of Indonesia’s pre-eclampsia: From obstetric intensive care with ventilator until epidemiologic and its molecular biology profile of pulmonary edema in severe pre-eclampsia. Pregnancy Hypertens 2014;4:245. doi: 10.1016/j.preghy.2014.04.018.

Savaj S, Vaziri N. An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran J Kidney Dis 2012;6:334-8. doi: 10.1073/pnas.. 1816150116.

Sheridan MA, Yang Y, Jain A, et al. Early onset preeclampsia in a model for human placental trophoblast. PNAS. 2019;116:4336-45. doi: 10.1073/pnas.. 1816150116.

Meeme A, Buga GA, Mammen M, Namugowa AV. Angiogenic imbalance as a contributor to the pathophysiology of preeclampsia among black African women. J Matern Fetal Neonatal Med 2017;30:1335-41. doi: 10.1080/14767058.2016. 1212832.

Li X, Dong X, Xue Y, Li C, Gou W, Chen Q. Increased expression levels of E-cadherin, cytokeratin 18 and 19 observed in preeclampsia were not correlated with disease severity. Placenta 2014;35:625-31. doi: 10.1016/j.placenta.2014. 04.010.

Laskowska M. Altered maternal serum matrix metalloproteinases MMP-2, MMP-3, MMP-9, and MMP-13 in severe early-and late-onset preeclampsia. Bio Med Res Int 2017;2017. https://doi.org/10.1155/2017/6432426.

Maître JL, Heisenberg CP. Three functions of cadherins in cell adhesion. Curr Biol 2013;23:R626-R33. doi: 10.106/j.cub.2013.06.019.

Howard S, Deroo T, Fujita Y, Itasaki N. A positive role of cadherin in Wnt/â-catenin signalling during epithelial-mesenchymal transition. PLoS One 2011;6:e23899. doi: 10.1371/journal.pone. 0023899.

Zhao HB, Wang C, Li RX, et al. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway. Biol Reprod 2010 ;83:370-6. doi: 10.1095/biolreprod.110.083402.

Zhang Y, Li P, Guo Y, Liu X, Zhang Y. MMP-9 and TIMP-1 in placenta of hypertensive disorder complicating pregnancy. Exp Ther Med 2019;18:637-41. doi: 10.3892/etm.2019.7591.

Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology 2013;28:391-403. doi: 10.1152/physiol.00029.2013.

Han S, Han L, Sun H, et al. Krüppel like factor expression and correlation with FAK, MMP 9 and E cadherin expression in hepatocellular carcinoma. Mol Med Report 2013;8:81-8. doi: 10.3892/mmr. 2013.1471.

Sosa EY, Flores-Pliego A, Espejel-Nuñez A, et al. New insights into the role of matrix metalloproteinases in preeclampsia. Int J Mol Sci 2017;18:1448. doi: 10.3390/ijms18071448.

Palei AC, Sandrim VC, Amaral LM, et al. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy. Exp Mol Pathol 2012;92:217-21. doi: 10.1016/j.yexmp. 2012.01.008.

Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L for the Global Pregnancy Collaboration. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension 2021;77:1430–41. DOI: 10.1161/HYPERTENSIONAHA.120.14781.

Meng H, Qi M, Liu Y, Xu L, Li Q. Research on correlation between MMP-9 and early-onset preeclampsia. Int J Clin Exp Med 2016;9:17442-8.

Li XL, Dong X, Xue Y, Li CF, Gou WL, Chen Q. Increased expression levels of E-cadherin, observed in preeclampsia were not correlated with disease severity. Placenta 2014;35:625-31. doi: 10.1016/j.placenta.2014.04.010.

Gomathy E, Akurati L, Radhika K. Early onset and late onset preeclampsia-maternal and perinatal outcomes in a rural teritiary health center. Int J Reprod Contracept Obstet Gynecol 2018;7:2266-9. https://dx.doi.org/10.18203/2320-1770. ijrcog20182333.

Dong X, Gou W, Li C, et al. Proteinuria in preeclampsia: Not essential to diagnosis but related to disease severity and fetal outcomes. Pregnancy Hypertens 2017;8:60-4. doi: 10.1016/j.preghy.2017.03.005.

Brown MA, Magee LA, Kenny LC, et al. on behalf of the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy : ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018;72:24-43. DOI: 10.1161/HYPERTENSIONAHA.117.10803.

Timokhina E, Strizhakov A, Ibragimova S, et al. Matrix metalloproteinases MMP-2 and MMP-9 occupy a new role in severe preeclampsia. J Pregnancy 2020;2020. https://doi.org/10.1155/2020/8369645.

Laskowska M. Maternal serum matrix metalloproteinase 9 in pregnancies complicated by severe preeclampsia and/or intrauterine fetal growth restriction. MOJ Women’s Health 2017;4:127-31. doi: 10.15406/mojwh.2017.04.00099.

Osman SE, Salih M, Ahmed EM, Mohammed AA, Adam I. Expression of E-cadherin, N-cadherin, and cytokeratin 18 and 19 in placentas of women with severe preeclampsia. Open Access Macedonian J Med Sci 2020;8:485-9. doi: 10.3889/oamjms.2020.4004.

Du L, Kuang L, He F, Tang W, Sun W, Chen D. Mesenchymal-to-epithelial transition in the placental tissues of patients with preeclampsia. Hypertens Res 2017;40:67-72. doi: 10.1038/hr.2016.97.